Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 15, 2020 - Issue
Submit an article Journal homepage
163
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Symptom Improvement Following Treatment with the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients with Moderate to Severe COPD – A Detailed Analysis

Henrik Watz1 Pulmonary Research Institute at Lung Clinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Grosshansdorf, GermanyCorrespondence[email protected]
,
Kathleen Rickard2 Verona Pharma Plc, Raleigh, NC, USAORCID Iconhttps://orcid.org/0000-0002-2542-6011
ORCID Icon,
Tara Rheault2 Verona Pharma Plc, Raleigh, NC, USA
,
Thomas Bengtsson3 StatMind AB, Lund, Sweden
&
Dave Singh4 Medicines Evaluation Unit, University of Manchester & Manchester University NHS Foundation Trust, Manchester, UK
Pages 2199-2206 | Published online: 16 Sep 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.